Nicholas N. Kallas, Ph.D.

Representative Matters

• Represented Novartis v. Breckenridge, West-Ward and Par (Zortress® (everolimus)) for kidney and liver transplants) (D. Del., Fed. Cir., PTAB-IPR)
• Represented Novartis v. West-Ward (Afinitor® (everolimus)) for renal cell carcinoma and pancreatic neuroendocrine tumors) (D. Del., Fed. Cir., PTAB-IPR)
• Represented Novartis v. Par (Afinitor® (everolimus) for breast cancer) (D.Del.)
• Represented Novartis v. Breckenridge (Afinitor® (everolimus) for renal cell carcinoma, renal angiomyolipoma, and tuberous sclerosis complex) (D. Del., PTAB-IPR)
• Represented Novartis v. Mylan (Afinitor® Disperz (everolimus) for tuberous sclerosis complex with subependymal giant cell astrocytoma) (D. Del.)
• Served as lead counsel to Novartis and LTS Lohmann Therapie-Systeme v. Noven Pharmaceuticals Inc. (rivastigmine Alzheimer ’s disease transdermal patch) (D. Del.)
• Served as lead counsel to Novartis and LTS Lohmann Therapie-Systeme v. Watson and Actavis (rivastigmine Alzheimer’s disease transdermal patch) (D. Del.)
• Served as lead counsel to Novartis v. Apotex and Mylan (enteric coated mycophenolate sodium immunosuppressant drug) (D.N.J.)
• Served as lead counsel to Novartis v. Mylan (fluvastatin sodium, anti-cholesterol drug) (D.N.J.)
• Represented Novartis v. Teva (famciclovir herpes drug) (D.N.J.)
• Served as lead counsel to Novartis v. Mylan (letrozole breast cancer drug) (D.N.J.)
• Served as lead counsel to Novartis v. Watson, Sun and Dr. Reddy’s (rivastigmine tartrate Alzheimer’s disease drug) (S.D.N.Y.)
• Served as lead counsel to Novartis v. Apotex (calcitonin osteoporosis drug) (S.D.N.Y.) Novartis v. Dr. Reddy’s (terbinafine anti-fungal drug) (S.D.N.Y.)
• Represented Parker Laboratories v. Pharmaceutical Innovations (ultrasound transmission gel product) (S.D.N.Y.)
• Served as lead counsel to Novartis v. Abbott (cyclosporine microemulsion drug) (D. Del. and Fed. Cir.)
• Served as co-trial counsel to Grain Processing v. American Maize-Products (maltodextrin food additives) (N.D. Ill. and Fed. Cir.)
• Served as lead counsel to Ben Venue v. Novartis (pamidronate disodium drug) (D.N.J.) and Ciba-Geigy v. Crompton & Knowles (red monoazo sulphonic acid dyes) (E.D. Pa.)
• Represented S.C. Johnson & Son v. Gillette (shaving gel product) (D. Mass. and Fed. Cir.)
• Represented S.C. Johnson & Son v. Carter-Wallace (shaving gel product) (S.D.N.Y. and Fed. Cir.)

Representative Clients

• Novartis
• S.C. Johnson & Son

Education

• J.D. with honors The Ohio State University, Michael E. Moritz College of Law 1982
• Ph.D. Food Science The Ohio State University 1979
• M.S. Food Science The Ohio State University 1977
• B.S. Microbiology The Ohio State University 1974

Bar Admissions

• New York
• U.S. Patent and Trademark Office

Court Admissions

• U.S. Court of Appeals for the Federal Circuit
• U.S. District Court for the Southern District of New York
• U.S. District Court for the Eastern District of New York

Clients recognize Nick’s commitment, knowledge, and professionalism, noting that he “consistently does an excellent job” (Client Report Card, 2014). Clients who have worked with Nick “for 20 years, would refer him and his firm without hesitation” (U.S. News – The Best Lawyers, 2010 – 2011).

• Legal 500, Intellectual Property – Patents: Litigation (full coverage), 2019
• Super Lawyers, Top Intellectual Property Litigators, New York Metro, 2013 – 2015
• Managing Intellectual Property, IP Star, 2020, 2022 – 2023
• LMG Life Sciences, Life Sciences Star, 2020, 2022
• The Best Lawyers in America, Patent Law, 2023